These findings suggest that obesity in PCOS patients is associated with increased IL-1β expression and inflammation, and that metformin treatment reduces IL-1β levels in obese PCOS patients, highlighting its anti-inflammatory effects. The gene discussed is IL1B; the disease is polycystic ovary syndrome.